SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Biocon's partner launches Insulin Glargine in Japan

15 Jul 2016 Evaluate

Biocon’s, partner FUJIFILM Pharma Co., (FFP) has launched Insulin Glargine in Japan on July 15, 2016. This is pursuant to receiving approval for its Insulin Glargine from the Japanese regulator last quarter. Insulin Glargine BS Injection Kit (FFP) has been developed & manufactured by Biocon, and is being commercialized by FFP in Japan.

The product is a ready-to-use, prefilled disposable pen with 3 ml of 100IU Insulin Glargine. It will provide a high quality, yet affordable, world-class long-acting biosimilar basal Insulin Glargine for patients of diabetes in Japan. According to the International Diabetes Federation, there were 7.2 million people with diabetes in Japan in 2015.

The company through its partner aims to capture a significant share of the Japanese Glargine market of $144 million, which is the second largest market outside of North America & Europe and is largely dominated by disposable pens.

Biocon is India’s largest and Asia’s leading Biotechnology Company with a strategic focus on biopharmaceuticals and research services. It is a fully integrated, innovation-driven biopharma enterprise offering affordable solutions for chronic diseases to patient's worldwide.


Biocon Share Price

394.10 13.55 (3.56%)
11-May-2026 11:43 View Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 1877.25
Dr. Reddys Lab 1287.65
Cipla 1335.20
Zydus Lifesciences 946.45
Lupin 2242.00
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×